Logo of archdischfnArchives of Disease in Childhood - Fetal & NeonatalVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Arch Dis Child Fetal Neonatal Ed. 2001 Nov; 85(3): F177–F181.
PMCID: PMC1721325

Costs of different strategies for neonatal hearing screening: a modelling approach


OBJECTIVE—To compare the cost effectiveness of various strategies for neonatal hearing screening by estimating the cost per hearing impaired child detected.
DESIGN—Cost analyses with a simulation model, including a multivariate sensitivity analysis. Comparisons of the cost per child detected were made for: screening method (automated auditory brainstem response or otoacoustic emissions); number of stages in the screening process (two or three); target disorder (bilateral hearing loss or both unilateral and bilateral loss); location (at home or at a child health clinic).
SETTING—The Netherlands
TARGET POPULATION—All newborn infants not admitted to neonatal intensive care units.
MAIN OUTCOME MEASURE—Costs per child detected with a hearing loss of 40 dB or more in the better ear.
RESULTS—Costs of a three stage screening process in child health clinics are €39.0 (95% confidence interval 20.0 to 57.0) per child detected with automated auditory brainstem response compared with €25.0 (14.4 to 35.6) per child detected with otoacoustic emissions. A three stage screening process not only reduces the referral rates, but is also likely to cost less than a two stage process because of the lower cost of diagnostic facilities. The extra cost (over and above a screening programme detecting bilateral losses) of detecting one child with unilateral hearing loss is €1500-4000. With the currently available information, no preference can be expressed for a screening location.
CONCLUSIONS—Three stage screening with otoacoustic emissions is recommended. Whether screening at home is more cost effective than screening at a child health clinic needs further study.

Full Text

The Full Text of this article is available as a PDF (150K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Davis A, Bamford J, Wilson I, Ramkalawan T, Forshaw M, Wright S. A critical review of the role of neonatal hearing screening in the detection of congenital hearing impairment. Health Technol Assess. 1997;1(10):i–176. [PubMed]
  • Yoshinaga-Itano C, Sedey AL, Coulter DK, Mehl AL. Language of early- and later-identified children with hearing loss. Pediatrics. 1998 Nov;102(5):1161–1171. [PubMed]
  • Markides A. Age at fitting of hearing aids and speech intelligibility. Br J Audiol. 1986 May;20(2):165–167. [PubMed]
  • Ramkalawan TW, Davis AC. The effects of hearing loss and age of intervention on some language metrics in young hearing-impaired children. Br J Audiol. 1992 Apr;26(2):97–107. [PubMed]
  • Eilers RE, Oller DK. Infant vocalizations and the early diagnosis of severe hearing impairment. J Pediatr. 1994 Feb;124(2):199–203. [PubMed]
  • Lutman ME, Grandori F. Screening for neonatal hearing defects European consensus statement. Eur J Pediatr. 1999 Feb;158(2):95–96. [PubMed]
  • Oudesluys-Murphy AM, Harlaar J. Neonatal hearing screening with an automated auditory brainstem response screener in the infant's home. Acta Paediatr. 1997 Jun;86(6):651–655. [PubMed]
  • Verkerk PH. Twintig jaar landelijke screening op fenylketonurie in Nederland. Landelijke Begeleidingscommissie PKU. Ned Tijdschr Geneeskd. 1995 Nov 11;139(45):2302–2305. [PubMed]
  • Verkerk PH, Derksen-Lubsen G, Vulsma T, Loeber JG, de Vijlder JJ, Verbrugge HP. Evaluatie van een decennium neonatale screening op congenitale hypothyreoïdie in Nederland. Ned Tijdschr Geneeskd. 1993 Oct 23;137(43):2199–2205. [PubMed]
  • Maxon AB, White KR, Vohr BR, Behrens TR. Using transient evoked otoacoustic emissions for neonatal hearing screening. Br J Audiol. 1993 Apr;27(2):149–153. [PubMed]
  • Brookhouser PE. Sensorineural hearing loss in children. Pediatr Clin North Am. 1996 Dec;43(6):1195–1216. [PubMed]
  • Mehl AL, Thomson V. Newborn hearing screening: the great omission. Pediatrics. 1998 Jan;101(1):E4–E4. [PubMed]
  • Psarommatis IM, Tsakanikos MD, Kontorgianni AD, Ntouniadakis DE, Apostolopoulos NK. Profound hearing loss and presence of click-evoked otoacoustic emissions in the neonate: a report of two cases. Int J Pediatr Otorhinolaryngol. 1997 Apr 11;39(3):237–243. [PubMed]
  • Stevens JC, Hall DM, Davis A, Davies CM, Dixon S. The costs of early hearing screening in England and Wales. Arch Dis Child. 1998 Jan;78(1):14–19. [PMC free article] [PubMed]
  • Mason JA, Herrmann KR. Universal infant hearing screening by automated auditory brainstem response measurement. Pediatrics. 1998 Feb;101(2):221–228. [PubMed]
  • Maxon AB, White KR, Behrens TR, Vohr BR. Referral rates and cost efficiency in a universal newborn hearing screening program using transient evoked otoacoustic emissions. J Am Acad Audiol. 1995 Jul;6(4):271–277. [PubMed]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Group


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...